Author

R. Caeser

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Approach:genetic perturbation / CRISPR· 2 Research Focus:benchmarking· 1 Approach:biophysical modeling· 1

Frequent Co-Authors

A. Catozzi· 1 shared A. Kerr· 1 shared A. Lallo· 1 shared A. Mupo· 1 shared A. P. Wiita· 1 shared A. Vogt· 1 shared B. Davies-Williams· 1 shared B. J. P. Huntly· 1 shared

Activity by Year

2019-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Catozzi

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Functional Characterisation of the ATOH1 Molecular Subtype Indicates a Pro-Metastatic Role in Small Cell Lung Cancer

A. Catozzi, M. Peiris-Pages, S. Humphrey, M. Revill, D. Morgan, J. Roebuck, Y. Chen, B. Davies-Williams, A. Lallo, M. Galvin, S. P. Pearce, A. Kerr, L. Priest, V. Foy, M. Carter, , K. L. Simpson

The paper identifies ATOH1 as a pro-metastatic oncogenic driver in SCLC by showing its role in cell survival and metastasis suppression upon depletion.

bioRxiv · Feb 16, 2024 · PreprintCancer Biology

Signaling input from divergent pathways subverts malignant B-cell transformation

L. N. Chan, M. A. Murakami, M. E. Robinson, R. Caeser, T. Sadras, J. Lee, K. N. Cosgun, K. Kume, V. Khairnar, G. Xiao, M. Ahmed, E. Aghania, G. Deb, C. Hurtz, S. Shojaee, , M. Muschen

This study shows that malignant B-cell transformation requires convergence on a single oncogenic pathway, while divergent pathways can subvert transformation and are targets for new therapeutic strategies.

bioRxiv · Mar 12, 2020Cancer Biology

Genetic modification of primary human B cells generates translationally-relevant models of high-grade lymphoma

R. Caeser, M. Di Re, J. A. Krupka, J. Gao, M. Lara-Chica, J. M. L. Dias, S. L. Cooke, R. Fenner, Z. Usheva, H. Runge, P. A. Beer, H. Eldaly, H.-K. Pak, C.-S. Park, G. Vassiliou, , D. J. Hodson

This study generates synthetic lymphoma models by genetically modifying primary human B cells to investigate oncogenic mutations in DLBCL.

bioRxiv · Apr 26, 2019 · PreprintCancer Biology